We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Cancer Conference Poster Prize Winner

Read time: Less than a minute

AMSBIO, regular sponsor of the annual Beatson International Cancer Conference has announced that the winner of the AMSBIO-Trevigen prize for the best poster was Katarzyna Grzes - a PhD researcher specializing in Cell Signaling and Immunology at the University of Dundee (Scotland, UK).

Miss Grzes was named as winner of the Poster Prize for the best presented and most interesting poster for her work entitled 'Metabolic regulation in PTEN null T lymphoma / leukemia'.

As one of Cancer Research UK’s core-funded institutes - the Beatson Institute (www.beatson.gla.ac.uk/) carries out a program of world-class science directed at understanding key aspects of cancer cell behaviour, and try to translate these discoveries into new therapies and diagnostic/prognostic tools to help cancer patients.

The Institute benefits from close interactions with the University of Glasgow, including strong links with the University’s Institute of Cancer Sciences.

AMSBIO is a rapidly growing company focused on the supply and development of products and technology for cancer research with emphasize on apoptosis, DNA damage and repair, and cancer cell function and behavior.

AMSBIO supplies focused research products for cancer research that allow researchers to study cancer cell function and behavior including in angiogenesis, cell invasion and PARP and PARG research.

Together with specifically designing assays for lead compound and genotoxic screening based on DNA damage and repair and cancer cell behavior, AMSBIO is establishing itself as a leading international provider of cancer research tools and services.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.